![REGENXBIO Announces FDA Clearance of IND for Clinical Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy · BioBuzz REGENXBIO Announces FDA Clearance of IND for Clinical Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy · BioBuzz](https://biobuzz.io/wp-content/uploads/2021/11/regenxbio-e1646230184363.png)
REGENXBIO Announces FDA Clearance of IND for Clinical Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy · BioBuzz
![CureDuchenne Congratulates Pfizer on Dosing First Patient in Phase III Clinical Trial for Duchenne Muscular Dystrophy - CureDuchenne CureDuchenne Congratulates Pfizer on Dosing First Patient in Phase III Clinical Trial for Duchenne Muscular Dystrophy - CureDuchenne](https://www.cureduchenne.org/wp-content/uploads/2021/01/pfizer-news-header.jpg)
CureDuchenne Congratulates Pfizer on Dosing First Patient in Phase III Clinical Trial for Duchenne Muscular Dystrophy - CureDuchenne
![Clinical trial of gene therapy for Duchenne muscular dystrophy underway at University of Florida Health | UF Health, University of Florida Health Clinical trial of gene therapy for Duchenne muscular dystrophy underway at University of Florida Health | UF Health, University of Florida Health](https://m.ufhealth.org/sites/default/files/styles/large/public/Peds%20Team-MCM-0739.jpg?itok=MXRRnv1S)
Clinical trial of gene therapy for Duchenne muscular dystrophy underway at University of Florida Health | UF Health, University of Florida Health
![Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials - Neuromuscular Disorders Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials - Neuromuscular Disorders](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d717f976-4ab1-468e-af8a-8833b73ea76f/nmd3401-fig-0001.jpg)
Delayed onset of ambulation in boys with Duchenne muscular dystrophy: Potential use as an endpoint in clinical trials - Neuromuscular Disorders
![Bayesian adaptive design for clinical trials in Duchenne muscular dystrophy - Lake - 2021 - Statistics in Medicine - Wiley Online Library Bayesian adaptive design for clinical trials in Duchenne muscular dystrophy - Lake - 2021 - Statistics in Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f57497d7-daa8-4581-a577-6023aa512a7a/sim9021-fig-0001-m.jpg)
Bayesian adaptive design for clinical trials in Duchenne muscular dystrophy - Lake - 2021 - Statistics in Medicine - Wiley Online Library
![VISION-DMD – Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy VISION-DMD – Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy](https://vision-dmd.info/vision1/wp-content/uploads/2018/03/brochure-front-e1532944214613.jpg)
VISION-DMD – Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy
![Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy - Zambon - 2022 - Developmental Medicine & Child Neurology - Wiley Online Library Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy - Zambon - 2022 - Developmental Medicine & Child Neurology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/db234b18-ca9b-4946-b586-a3f3ad324084/dmcn15176-toc-0001-m.jpg)
Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy - Zambon - 2022 - Developmental Medicine & Child Neurology - Wiley Online Library
![Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG) - Neuromuscular Disorders Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG) - Neuromuscular Disorders](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1306300/9008686/gr1.jpg)